D. Sur, A. Havasi, C. V. Lungulescu, S. R. Volovat, C. Burz, and A. Irimie, “Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review”, Medicine and Pharmacy Reports, vol. 95, no. 3, pp. 251–259, May 2022.